BIT biotron limited

0.00%

0.2¢

Ann: Response to ASX Query Letter, page-113

First 113 Last

Share
Profile

Follow
Footmax

15,556 Posts.

2773

24/03/25

13:21

Post #: 78389900
Share

Will be of interest then that, if the DR were to fail, would another company just offer the MC of $3mil to pick up BIT in full. I could serve as a shell company to get into the ASX.

Thanks for the info re the rights take up. 29mil shares is peanuts in reality and it does look like investors have woken up to the fact that BIT is pretty much without any use as a research engine in the biotech sector. Low trading volume at the current SP reinforces that.

Depending on the take up of the CR, we could see some trying to get the SP up afterwards so they can off-load what they picked up in the CR.

Interesting time ahead.

Originally posted by GiddyYup: ↑

Hey guys, can we discuss the other turd for a moment, ie the CR?

Just looking at the available data to see how the rights issue is progressing. Whilst there was an initial round of buying of rights on market that appears to have almost completely dried up now. A total of around 29m rights were purchased on market (out of the 910m rights issued). I lean toward the assumption that if somebody purchased rights then they are likely to exercise them in the absence of the SP falling below 0.003, although there is also the possibility that a few thought they would take a punt hoping for good news from C14 before the CR closed. That CR window drops by 20% each day hereafter.

The total value of those rights to Biotron's CR if exercised in full is only $87k.

I don't know who purchased these rights but its worth noting that the on market trading of BIT heads has also dropped to near zero on a daily basis since the massive rush for the exits when the rights issue was announced. The stock is now almost completely ill-liquid as was the case during past CRs. Sadly after past CRs the price then dropped below the issue price for a good 6 to 12 months. Not sure that many here have confidence to look that far out this time around so we are in uncharted territory now.

The closing date for rights acceptances is only a week away. There are some people who know how many have paid up but most of us here are not amongst them.

I also note that many of the most vocal and bullish posters have completely disappeared from HC. General interest seems to have dropped off a cliff. Did they all sell out weeks ago when the SPP was announced and quietly disappear into the night? This has the feeling of complete capitulation.

I know that the board did say that they "intended" to participate to some extent but if nobody else did then Mahe picks up 250m shares which when added to the current issued capital is 21.5%. I find this an interesting possibility since an underwriter is generally exempt from the 20% cap within the takeovers act for obvious reasons. Who is Mahe going to unload all of these shares onto? At the current turnover of BIT stock on market it would take 112 years to sell that many (yes, that might be a slight exaggeration) !

The big question in my mind is this; in the absence of any offer for the IP (with or without C14) why have we not seen an offer from an Aussie biotech looking to pickup the massive losses? I'm not an accountant but I would assume those have an underlying value of around $18m to any profitable biotech paying tax in Australia. Clearly there would be no point paying full face value for the losses because you would only break even but even at a discount of 50% that would still be 3 times current market cap, excluding the transaction costs. Is it just too small for any business focused biotech to worry about? Maybe one of the CPAs amongst us has some ideas on this !

Expand

BIT Price at posting: 0.3¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

PIQ

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

First 113 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$80	40K

Buyers (Bids)

No.	Vol.	Price($)
51	42998758	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	19056424	30

View Market Depth

No.	Vol.	Price($)
45	38565424	0.002
32	71031001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	13789780	25
0.004	12487636	16
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 11.19am 20/06/2025 (20 minute delay)

BIT (ASX) Chart

Ann: Response to ASX Query Letter, page-113

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Response to ASX Query Letter, page-113

Top Stories

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News